Pending Litigation Delays Implementation Of SUNSET Regulation Review Policy To 2022
Executive Summary
HHS says trying to implement the rule while it is still being litigated could create confusion for the public, among other problems.
You may also be interested in...
Groups Sue To Stop ‘Ticking Time Bomb’ Of SUNSET Reg Review Proposal
The lawsuit argues that the regulatory review proposal was “arbitrary and capricious” and should not be allowed to go into effect.
Biden Regulatory Freeze May Pause SUNSET Rule
Tactic aims to allow incoming Administration to scrutinize so-called ‘midnight rules’ issued in the final days of the Trump Administration before they take effect. Regulators may also solicit stakeholder comments on delayed rules.
For Second Time This Month, Medtronic Announces Class I FDA Recall Related To HeartWare System Component
Medtronic, Baxter and BD are all facing recalls, with Medtronic finding yet another issue with HeartWare HVAD systems. Separately, the FDA put a Baxter respiratory device recall into Class I, and BD announced a recall on intraosseous devices.